Published in Mol Cell Biochem on June 01, 1999
Protective effects of hydroalcoholic extract from rhizomes of Cynodon dactylon (L.) Pers. on compensated right heart failure in rats. BMC Complement Altern Med (2009) 1.01
Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol (2010) 1.00
Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model. Respir Res (2011) 0.89
Role of oxidized lipids in pulmonary arterial hypertension. Pulm Circ (2016) 0.77
Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction. Mol Cell Biochem (2017) 0.75
Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol (1982) 1.87
The role of oxidative stress in the genesis of heart disease. Cardiovasc Res (1998) 1.85
Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol (1996) 1.57
Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol (2007) 1.52
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation (1997) 1.50
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Free radicals and the heart. J Pharmacol Toxicol Methods (1993) 1.27
Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol (1994) 1.26
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal (2001) 1.19
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation (1994) 1.16
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med (1999) 1.14
Oxidative stress and heart failure. Mol Cell Biochem (1996) 1.12
Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol (1995) 1.11
Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol (2000) 1.09
Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation (1995) 1.07
Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol (1991) 1.07
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem (2003) 1.06
Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol (1991) 1.03
Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep (1998) 1.02
Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation (2000) 1.02
Quantitative measurement of patellofemoral joint stability: force-displacement behavior of the human patella in vitro. J Orthop Res (2003) 1.01
Metallothioneins, oxidative stress and the cardiovascular system. Toxicology (2000) 1.01
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol (2005) 0.99
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol (1997) 0.95
Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol (1985) 0.94
Heart sounds separation from lung sounds using independent component analysis. Conf Proc IEEE Eng Med Biol Soc (2005) 0.92
Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol (1993) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol (1984) 0.92
An ultrastructural study of the first cleavage of Xenopus embryos. J Ultrastruct Res (1974) 0.92
Oxidative stress in congestive heart failure. Curr Cardiol Rep (2000) 0.91
Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol (1995) 0.90
Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol (1989) 0.90
Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res (1989) 0.90
Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur J Pharm Sci (2006) 0.90
Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res (2000) 0.89
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol (1991) 0.87
The effects of trochlear groove geometry on patellofemoral joint stability--a computer model study. Proc Inst Mech Eng H (2008) 0.87
Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation (1999) 0.86
Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies. Lab Invest (1981) 0.86
Influence of reducing agents on adrenochrome-induced changes in the heart. Arch Pathol Lab Med (1981) 0.86
Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J Mol Cell Cardiol (1999) 0.86
Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem (1997) 0.86
Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol (1988) 0.85
Role of Na+-Ca2+ exchange in the development of cardiac abnormalities due to calcium paradox. Eur Heart J (1983) 0.84
Design and evaluation of a novel triaxial isometric trunk muscle strength measurement system. Proc Inst Mech Eng H (2009) 0.84
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Anticancer Res (2008) 0.84
Cytomembranes in first cleavage Xenopus embryos. Interrelationship between Golgi bodies, endoplasmic reticulum and lipid droplets. Cell Tissue Res (1974) 0.84
Oxidative stress and functional deficit in diabetic cardiomyopathy. Adv Exp Med Biol (2001) 0.84
Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure. J Mol Cell Cardiol (2004) 0.84
Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial. Minerva Pediatr (2008) 0.84
Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats. Can J Physiol Pharmacol (1987) 0.83
Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function. Am J Physiol (1986) 0.83
Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide. Mol Cell Biochem (2000) 0.83
Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem (1998) 0.83
The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J Mol Endocrinol (2008) 0.83
Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol (2001) 0.82
Design and development of a hand robotic rehabilitation device for post stroke patients. Conf Proc IEEE Eng Med Biol Soc (2009) 0.82
Ca2+- and Mg2+-dependent ATPase activities in the deoxycholate-treated rat heart sarcolemma. Int J Biochem (1982) 0.82
Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol (2006) 0.81
Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. Am Heart J (1981) 0.81
Myocardial cell damage and cardiovascular changes due to i.v. infusion of adrenochrome in rats. Br J Exp Pathol (1982) 0.81
Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol (1992) 0.81
Negatively charged sites and calcium binding in the isolated rat heart sarcolemma. Basic Res Cardiol (1981) 0.81
Circaannual changes in antioxidants and oxidative stress in the heart and liver in rats. Comp Biochem Physiol C Toxicol Pharmacol (2000) 0.81
Metabolism of vitamin A in the heart increases after a myocardial infarction. Free Radic Biol Med (1999) 0.80
Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations. Lab Invest (1980) 0.80
Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition (1996) 0.80
Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities. Can J Physiol Pharmacol (1979) 0.80
Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest (1992) 0.80
Effects of methionine on endogenous antioxidants in the heart. Am J Physiol (1999) 0.80
Myocardial heterogeneity and regional variations in response to injury. Lab Invest (1992) 0.80
Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol (1997) 0.80
Subcellular distribution of cardiac 5'-nucleotidase: alteration of microsomal pool in hypertrophied pig heart. J Mol Cell Cardiol (1986) 0.80
Progress and problems in understanding the involvement of calcium in heart function. Can J Physiol Pharmacol (1984) 0.79
Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart. Can J Cardiol (1986) 0.79
Cytochemical and immunocytochemical localization of Na,K-ATPase alpha subunit isoenzymes in the rat heart. Mol Cell Biochem (1997) 0.79
Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Mol Cell Biochem (1999) 0.79
Subcellular changes during cardiac hypertrophy and heart failure due to bacterial endocarditis. Basic Res Cardiol (1980) 0.78
Time-course of cardiac myocyte injury due to oxidative stress. Mol Cell Biochem (1992) 0.78
Protection against adrenochrome-induced myocardial damage by various pharmacological interventions. Br J Exp Pathol (1980) 0.78
Mode of formation of giant cells in testicular hyperthermia. Fertil Steril (1971) 0.78
Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol (1997) 0.78
Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can J Cardiol (1996) 0.78
Occurrence of intramitochondrial Ca2+ granules in a hypertrophied heart exposed to adriamycin. Can J Physiol Pharmacol (1984) 0.78
Alterations in heart sarcolemmal Ca2(+)-ATPase and Ca2(+)-binding activities due to oxygen free radicals. Basic Res Cardiol (1990) 0.77
Sarcoplasmic reticular Ca2+-pump adaptation in cardiac hypertrophy due to pressure overload in pigs. Eur Heart J (1984) 0.77
Cardiac cell damage: a primary myocardial disease in streptozotocin-induced chronic diabetes. Br J Exp Pathol (1984) 0.77
Structure-function relationship in heart sarcolemma. Adv Myocardiol (1980) 0.77
Reversibility of ultrastructural, contractile function and Ca2+ transport changes in guinea pig hearts after global ischemia. Can J Physiol Pharmacol (1986) 0.77
Adriamycin does have a potentially depressant effect on left ventricular contractility. Int J Cardiol (1985) 0.77
Extracellular calcium and positive inotropy of ionophore (X537-A) in cardiac muscle. Jpn J Physiol (1976) 0.77